Antimalarials in cutaneous lupus erythematosus: mechanisms of therapeutic benefit.
Wozniacka, A
Antimalarials in cutaneous lupus erythematosus: mechanisms of therapeutic benefit. [electronic resource] - Lupus 2002 - 71-81 p. digital
Publication Type: Journal Article; Review
0961-2033
10.1191/0961203302lu147rr doi
Antimalarials--pharmacokinetics
Apoptosis--drug effects
Blood Platelets--drug effects
Glucose
Humans
Lipid Peroxidation--drug effects
Lupus Erythematosus, Cutaneous--drug therapy
Lysosomes--drug effects
Prostaglandins--biosynthesis
T-Lymphocytes, Cytotoxic--drug effects
Antimalarials in cutaneous lupus erythematosus: mechanisms of therapeutic benefit. [electronic resource] - Lupus 2002 - 71-81 p. digital
Publication Type: Journal Article; Review
0961-2033
10.1191/0961203302lu147rr doi
Antimalarials--pharmacokinetics
Apoptosis--drug effects
Blood Platelets--drug effects
Glucose
Humans
Lipid Peroxidation--drug effects
Lupus Erythematosus, Cutaneous--drug therapy
Lysosomes--drug effects
Prostaglandins--biosynthesis
T-Lymphocytes, Cytotoxic--drug effects